Dr. Sameer Tulpule
Senior Director – Haematology & BMT (Adult)
Nanavati Max Institute of Cancer Care, Centre for Haematology & Bone Marrow Transplant, Hemato-Oncology & Bone Marrow Transplant, Allogeneic Bone Marrow Transplantation, Allogeneic Transplant, Autologous Transplant
Nanavati Max Super Speciality Hospital, Mumbai
Experience: 17+ Years
Share Doctor Profile
Select Hospital
About Dr. Sameer Tulpule
- Senior Director – Haematology & BMT, Nanavati Max Super Speciality Hospital, Mumbai (June 2025 - Present)
- Consultant – Haematology & Stem Cell Transplantation, Kokilaben Dhirubhai Ambani Hospital, Mumbai (Oct 2015 - May 2025)
- Consultant – Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, UK (Nov 2013 - Oct 2015)
- Fellow (Post-CCT) – Bone Marrow Transplant, Nottingham University Hospitals NHS Trust, UK (Apr 2013 - Oct 2013)
- Locum Consultant – Haematology, Northwick Park Hospital, NWLH NHS Trust, London (Aug 2012 - Apr 2013)
- Medical Officer & Research Fellow – Stem Cell Transplant, Anthony Nolan Trust, London (Aug 2009 - Aug 2011)
- FRCPath, Royal College of Pathologists, UK (2011)
- MRCP, Royal College of Physicians, UK (2004)
- MD (Medicine), Jawaharlal Nehru Medical College & KLES Hospital, Rajiv Gandhi University of Health Sciences, Bangalore (1999)
- MBBS, Seth G.S. Medical College & K.E.M. Hospital, University of Mumbai (1993)
- Indian Society of Haematology & Blood Transfusion (ISHBT)
- British Society of Haematology (BSH)
- American Society of Hematology (ASH)
- European Society for Blood & Marrow Transplantation (EBMT)
- “Best Outgoing Resident” in Medicine – 4th Karnataka State Conference, API & CSI
- University distinctions in Pathology & Pharmacology
- Second rank in MBBS, University of Bombay
- Bone Marrow Transplantation (Autologous, Allogeneic & Haploidentical)
- CAR-T Cell Therapy
- Acute & Chronic Leukaemias
- Multiple Myeloma
- Lymphomas (Including Targeted Therapies)
- Anaemia (Including Thalassaemia)
- Polycythaemia
- Platelet & White Cell Disorders
- Bleeding & Clotting Disorders
- “Rejection of Paternal vs Maternal Fully Matched Bone Marrow Grafts in Children with Thalassaemia” (Co-author, 2017)
- “A Multicentre Retrospective UK Study Detailing Onset of Graft Versus Host Disease… Following Haematopoietic Stem Cell Transplantation” (Co-author, 2015)
- “Subsequent Donation Requests Among 2472 Unrelated Hematopoietic Progenitor Cell Donors Are Associated with Bone Marrow Harvest” (Co-author, 2013)
- “Immune Reconstitution in Cord Blood Transplantation” – CML, Leukemia & Lymphoma (Co-author, 2011)
- “Severe Allergic Reaction with Anaphylaxis to G-CSF (Lenograstim) in a Healthy Donor” (Co-author, 2009)
- “Management and Outcome of Four Pregnancies in Women with Idiopathic Myelofibrosis” – Br J Haematol (Co-author, 2008)
- “Safety and Efficacy of Mycophenolate Mofetil in Relapsing Acquired Thrombotic Thrombocytopenic Purpura” – ASH Abstract (Co-author, 2006)
- “Standardisation and Validation of PCR Fragment Analysis-Based Assay for Detection of Mixed Donor Chimerism in Haematopoietic Stem Cell Transplant Recipients” – Can J Biotechnol (Author, 2017)